Acta Scientific Microbiology (ISSN: 2581-3226)

Short Communication Volume 5 Issue 2

Shortening the Isolation and Quarantine Period for the General Population in the Era of COVID-19 Pandemic

Attapon Cheepsattayakorn1,2*, Ruangrong Cheepsattayakorn3 and Porntep Siriwanarangsun1

1Faculty of Medicine, Western University, Pathumtani Province, Thailand

210th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand

3Department of Pathology, Faculty of Medicine, Chiang Mai University, Chiang Mai, Thailand

*Corresponding Author: Attapon Cheepsattayakorn, 10th Zonal Tuberculosis and Chest Disease Center, Chiang Mai, Thailand.

Received: December 31, 2021; Published: January 10, 2022

Abstract

Currently, Brazil, Germany, and Jordan are following the World Health Organization (WHO)’s recommendation of 14 day isolation period [1]. The isolation period in France and Japan is 10 days, whereas in New Zealand, if the individual is fully vaccinated with 72 hours of free symptoms, the isolation period is 10 days, but it is 14 days if they are unvaccinated with 72 hours of free symptoms [1]. The United States Centers for Disease Control and Prevention (US CDC) is now shortening the recommended isolation time for the public by motivated change through science showing that the majority of SARS-CoV-2 (COVID-19) transmission, including the Omicron variant transmission generally occur in the 1-2 days before and 2-3 days after the symptom onset [2].

References

  1. Mahase E. “COVID-19 : is it safe to reduce the self-isolation period?” British Medical Journal 375 (2021): n3164.
  2. United Stated Centers for Disease Control and Prevention. “CDC updates and shortens recommended isolation and quarantine period for general population” (2021).

Citation

Citation: Attapon Cheepsattayakorn., et al. “Shortening the Isolation and Quarantine Period for the General Population in the Era of COVID-19 Pandemic". Acta Scientific Microbiology 5.2 (2022): 20.

Copyright

Copyright: © 2022 Attapon Cheepsattayakorn., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.




Metrics

Acceptance rate30%
Acceptance to publication20-30 days

Indexed In






News and Events


Contact US